Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 285

1.

Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo.

Uchi H, Stan R, Turk MJ, Engelhorn ME, Rizzuto GA, Goldberg SM, Wolchok JD, Houghton AN.

Adv Immunol. 2006;90:215-41. Review.

PMID:
16730265
2.

Multiple pathways to tumor immunity and concomitant autoimmunity.

Turk MJ, Wolchok JD, Guevara-Patino JA, Goldberg SM, Houghton AN.

Immunol Rev. 2002 Oct;188:122-35. Review.

PMID:
12445286
3.

Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity.

Ramirez-Montagut T, Turk MJ, Wolchok JD, Guevara-Patino JA, Houghton AN.

Oncogene. 2003 May 19;22(20):3180-7. Review.

PMID:
12789294
4.

Autoimmunity as an aetiological factor in vitiligo.

Rezaei N, Gavalas NG, Weetman AP, Kemp EH.

J Eur Acad Dermatol Venereol. 2007 Aug;21(7):865-76. Review.

PMID:
17658994
5.

Autoimmune aspects of vitiligo.

Kemp EH, Waterman EA, Weetman AP.

Autoimmunity. 2001;34(1):65-77. Review.

PMID:
11681494
6.

Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo).

Merimsky O, Shoenfeld Y, Baharav E, Zigelman R, Fishman P.

Hum Antibodies Hybridomas. 1996;7(4):151-6.

PMID:
9140726
7.

Harnessing autoimmunity (vitiligo) to treat melanoma: a myth or reality?

Ram M, Shoenfeld Y.

Ann N Y Acad Sci. 2007 Sep;1110:410-25. Review.

PMID:
17911456
8.

Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy.

Engelhard VH, Bullock TN, Colella TA, Sheasley SL, Mullins DW.

Immunol Rev. 2002 Oct;188:136-46. Review.

PMID:
12445287
9.

Immune mechanisms in vitiligo.

Bystryn JC.

Immunol Ser. 1989;46:447-73. Review.

PMID:
2488866
10.

Immunity to cancer through immune recognition of altered self: studies with melanoma.

Guevara-Patiño JA, Turk MJ, Wolchok JD, Houghton AN.

Adv Cancer Res. 2003;90:157-77. Review.

PMID:
14710950
11.

Autoimmune etiology of generalized vitiligo.

Le Poole IC, Luiten RM.

Curr Dir Autoimmun. 2008;10:227-43. doi: 10.1159/000131485. Review.

PMID:
18460889
12.

A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo.

Das PK, van den Wijngaard RM, Wankowicz-Kalinska A, Le Poole IC.

Trends Immunol. 2001 Mar;22(3):130-6. Review.

PMID:
11286727
13.

Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.

Kiniwa Y, Fujita T, Akada M, Ito K, Shofuda T, Suzuki Y, Yamamoto A, Saida T, Kawakami Y.

Cancer Res. 2001 Nov 1;61(21):7900-7.

14.

Autoantibodies to tyrosinase: the bridge between melanoma and vitiligo.

Fishman P, Merimski O, Baharav E, Shoenfeld Y.

Cancer. 1997 Apr 15;79(8):1461-4.

PMID:
9118024
15.

Antibodies to normal human melanocytes in vitiligo.

Naughton GK, Eisinger M, Bystryn JC.

J Exp Med. 1983 Jul 1;158(1):246-51.

16.

Expansion of vitiligo lesions is associated with reduced epidermal CDw60 expression and increased expression of HLA-DR in perilesional skin.

Le Poole IC, Stennett LS, Bonish BK, Dee L, Robinson JK, Hernandez C, Hann SK, Nickoloff BJ.

Br J Dermatol. 2003 Oct;149(4):739-48.

PMID:
14616364
17.

[Humoral and cellular autoimmunity in genuine vitiligo studied by means of an antigen produced from melanoma cells].

Höfs T.

Folia Haematol Int Mag Klin Morphol Blutforsch. 1982;109(2):244-50. German.

PMID:
6179826
18.
19.

Current remedies for vitiligo.

Abu Tahir M, Pramod K, Ansari SH, Ali J.

Autoimmun Rev. 2010 May;9(7):516-20. doi: 10.1016/j.autrev.2010.02.013. Epub 2010 Feb 8. Review.

PMID:
20149899
20.

Recognition of autoantigens by patients with melanoma.

Houghton AN, Vijayasaradhi S, Bouchard B, Naftzger C, Hara I, Chapman PB.

Ann N Y Acad Sci. 1993 Aug 12;690:59-68. Review. No abstract available.

PMID:
8368771

Supplemental Content

Support Center